相关实验视频

Updated: Jul 6, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K

特拉美提尼布的敏感性是由急性髓性白血病中的骨髓分化特征定义的

Mathieu Quesnel-Vallières1,2,3, David C Schultz1,4, Alena Orlenko4,5

  • 1Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, 19104, USA.

Drugs in R&D
|September 24, 2024
PubMed
概括

这项研究揭示了某些急性髓性白血病 (AML) 细胞对特拉美替尼反应,独立于RAS突变. 像CD14这样的单细胞分化标志物可以预测AML患者对特拉美丁尼的敏感性.

更多相关视频

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.2K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

39

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...